Novoeight® receives approval from the FDA
Bagsværd, Denmark  – Today, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved its Biologics License Application (BLA) for recombinant coagulation factor VIII, Novoeight®.The FDA approved Novoeight® for use in adults and children with haemophilia A for: ï‚· Control and prevention of bleeding ï‚· Perioperative management ï‚· Routine prophylaxis to prevent […]
Infusing Love: Standing Up (In a Wheelchair) to Bullying
Thomas’s first day of third grade was spent in a wheelchair, thanks to an ankle bleed. It certainly wasn’t the first time he had to attend school in the ‘chair,’ but I hated that it had to fall on the first day of school. We’ve always been very open about hemophilia – in first grade […]
English 
Español de Puerto Rico